期刊文献+

胃复安联合膳食改善对治疗ICU患者晚期胃癌化疗患者免疫功能及生活质量的影响 被引量:1

Effect of weifu'an combined with dietary improvement on immune function and quality of life in patients with advanced gastric cancer chemotherapy
下载PDF
导出
摘要 目的 探讨胃复安联合膳食改善对治疗ICU患者晚期胃癌化疗患者免疫功能及生活质量的影响.方法 回顾性分析天台县人民医院70例Ⅲ-Ⅳ期晚期胃癌患者临床病历资料与治疗情况;按照随机数字表法将其分为对照组(采用OLF方案化疗治疗)与观察组(化疗联合胃复安联合膳食改善),各35例,统计2组治疗4个疗程后临床疗效及不良反应情况,用卡氏生活质量(KPS)评分评价2组患者治疗前、后生存质量;检测2组患者治疗前后免疫功能.结果 观察组临床疾病控制率68.57%与对照组60.0%比较差异无统计学意义;观察组与对照组治疗后KPS评分,明显高于治疗前,且观察组KPS评分明显高于对照组,差异有统计学意义(P〈0.05).2组治疗前各项免疫功能指标相比较差异无统计学意义;对照组CD4+细胞、CD4+/CD8+及NK细胞水平较治疗前明显下降,差异有统计学意义(P〈0.05);且与观察组比较(P〈0.05).观察组不良反应率37.14%明显低于对照组68.57%,差异有统计学意义(P〈0.05).结论 胃复安联合膳食改善可减少不良反应,有助于改善患者免疫功能及生活质量. Objective To investigate the effect of Weifu'an combined with dietary improvement on immune function and quality of life in patients with advanced gastric cancer chemotherapy.MethodsAnalysis of hospital, 70 cases of Ⅲ-Ⅳ period clinical medical records and treatment in patients with advanced gastric cancer;According to random number table method will be divided into the control group (chemotherapy using OLF) and observation group (chemotherapy combined Weifu'an combined dietary improvement), and 35 cases statistics of two groups of clinical curative effect and adverse reactions after the treatment of four course, carr's quality of life (KPS) score was used to ealuate treatment in both groups before and after the survival quality.Detection in the two groups before and after treatment in patients with immune function.ResultsThe control rate of clinical disease was 68.57% in the observation group and 60.0% in the control group, there was no significant differemce.The KPS score of the observation group and the control group was significantly higher than that of the control group before the treatment and the KPS score of the observation group was significantly higher than that of the control group(P〈0.05).Compared with the observation group, the levels of CD4+/CD8+ and NK cells in the control group were significantly lower than those in the control group, the difference was statistically significant (P〈0.05).The adverse reaction rate was 37.14% in the observation group and 68.57% in the control group,the difference was statistically significant(P〈0.05).ConclusionWeifu'an combined dietary improvement can reduce adverse reactions, immune function and help to improve the patients quality of life.
作者 庞彩珍 范国峰 PANG Cai-zhen FAN Guo-feng(Department of Nutriology, Tiantai County People's Hospital, Taizhou 317200, China Department of Nutriology, Taizhou Central Hospital, Taizhou 318000, China)
出处 《中国生化药物杂志》 CAS 2017年第6期251-253,共3页 Chinese Journal of Biochemical Pharmaceutics
关键词 胃复安 膳食改善 晚期胃癌 OLF方案化疗 生活质量 Weifu'an diet improvement advanced gastric cancer OLF chemotherapy quality of life
  • 相关文献

参考文献8

二级参考文献59

  • 1成忠了,牛彦锋,王国斌,卢晓明,陈道达.早期肠内营养对胃癌术后近期免疫和营养状况的影响[J].肠外与肠内营养,2005,12(4):207-209. 被引量:8
  • 2李乐平,靖昌庆,刘洪俊,石玉龙,林立明.新辅助化疗联合肠外营养对胃癌细胞增殖活性的影响[J].中国临床营养杂志,2006,14(2):100-103. 被引量:5
  • 3张景芳,张原平,郝风云,张采欣,李玉军,纪祥瑞.胃癌DNA倍体分析及其TIMP-2和E-cadherin在胃癌中的表达[J].中国病理生理杂志,2006,22(7):1353-1358. 被引量:2
  • 4李海金,董良,李英.盐酸托烷司琼预防顺铂化疗所致恶心呕吐56例[J].肿瘤学杂志,2007,13(1):70-71. 被引量:2
  • 5S~mchez R, Alexander-Sierra F, Oliveros R. Relationship between quality of life and clinical status in patients with gastrointestinal cancer [J]. Rev Esp Enferm Dig, 2012,104: 584-591.
  • 6Cawsey SI, Soo J, Gramlich LM. Home enteral nutrition: outcomesrelative to indication[Jl. Nutr Clin Pract, 2010,25:296-300.
  • 7Brodowicz T, Ciuleanu TE, Radosavljevic D, et al. FOLFOX4 plus cetuximab administered weekly or every second week in the first-line treatment of patients with KRAS wild-type metastatic colorectal cancer: a randomized phase lI CECOG study[J]. Ann Oncol, 2013,24: 1769-1777.
  • 8Evers PD, Logan JE, Sills V, et al. Karnofsky Performance Status predicts overall survival, cancer-specific survival, and progression-free survival following radical cystectomy for urothelial carcinoma E J ]. World J Urol, 2013, In press.
  • 9Khan L, Cramarossa G, Lemke M, et al. Symptom clusters using the Spitzer quality of life index in patients with brain metastases-a reanalysis comparing different statistical methods [ J ]. Support Care Cancer, 2013,21:467-473.
  • 10Bedard G, Zeng L, Zhang L, et al. Minimal important differences in the EORTC QLQ-C30 in patients with advanced cancer[J]. Asia Pac J Clin Oneol, 2013,In press.

共引文献134

同被引文献7

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部